PUBLISHER: Allied Market Research | PRODUCT CODE: 1193095
PUBLISHER: Allied Market Research | PRODUCT CODE: 1193095
The global molecular cytogenetics market was valued at $2,233.5 million in 2021, and is projected to reach $5,146.55 million by 2031, registering a CAGR of 8.7%.
Molecular cytogenetics includes the chromosome biology and the use of molecular cytogenetic methods in biology and medicine. These include the structural and functional establishment of the chromosome and nucleus, genome variation, expression, and evolution, chromosome abnormalities, and genomic variations in tumor genetics and medical genetics. The testing includes identifying a specific gene or gene locus (molecular) with direct visualization of the cells and chromosomes under a fluorescence microscope and is far from being outdated and is actively involved in up-to-date diagnostics and research.
According to National Center for Biotechnology Information (NCBI), an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. This prevalence of cancer diseases among all age groups owing to changes (mutations) to the DNA within cells, will lead to the increase in the demand for diagnostic techniques of molecular cytogenetics.
Furthermore, the growth of the molecular cytogenetics market is anticipated to be facilitated by the introduction of numerous cutting-edge diagnostic technologies by the biotechnology companies, an increase in demand for accurate diagnosis of serious cancer diseases, and the availability of interventional pathologist with the necessary training in developed economies.
In addition, advancements in molecular cytogenetics, increase in incidence of genetic disorders & cancer and rise in awareness & acceptance of personalized medicines, are some of the factors that are boosting the market growth. The development of the techniques including interphase fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), multicolor karyotyping, telomere FISH, primed in situ labelling (PRINS), and telomere FISH, have caused the expansion of the market. However, the market is expected to be significantly constrained in the near future by factors such as high cost associated with the procedure.
In addition, the use of molecular pathology in disease diagnosis, disease prevention, and treatment is now possible using the molecular cytogenetics. For instance, the development of the BioPrime Total Genomic Labeling System by the Thermo Fisher Scientific, which is a complete genomic DNA labeling system designed for use in array comparative genomic hybridization applications (aCGH) that allows for better call rates with precious samples.
The molecular cytogenetics market is segmented on the basis of product, technique, application, end user and region. By product, it is divided into instruments, consumables, and software & services. On the basis of technique, the market is segmented into comparative genomic hybridization, fluorescence in situ hybridization and others. Further, the comparative genomic hybridization segment is divided into array-based comparative genomic hybridization and standard comparative genomic hybridization. By application, the market is segmented into genetic disorders, cancer, personalized medicine and others. According to the end user, the market is segmented into clinical & research laboratories, pharmaceutical & biotechnology companies and others (academic research institutes, contract research organization [CRO]). Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in this report include Abbott Laboratories, Agilent Technologies Inc., Applied Spectral Imaging, Cyto Test Inc., Danaher Corporation (Cephied), Empire Genomics, LLC., Genial Genetic Solutions Ltd., Illumina, Inc., Perkinelmer, Inc., Sema4 Holdings Corp., Sysmex Corporation (Oxford Gene Technology) and Thermo Fisher Scientific Inc. and among others.
Key Benefits For Stakeholders
By Product
By Technique
By Application
By End User
By Region